Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

GRAL

GRAIL Inc

Jan 02 • 02:06PM ET

17.74

Dollar change -0.11
Percentage change -0.61	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN EXAS GH PACB TXG QGEN CRSP EDIT CDNA FULC

| Held by: VTI XBI VXF IBB VHT IWR IWD LABU IWS ITOT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-67.93	Insider Own	14.25%	Shs Outstand	33.20M	Perf Week	-5.68%
Market Cap	596.11M	Forward P/E	-	EPS next Y	-	Insider Trans	-3.47%	Shs Float	28.81M	Perf Month	-5.28%
Income	-2117.47M	PEG	-	EPS next Q	-4.73	Inst Own	66.96%	Short Float	16.99%	Perf Quarter	33.90%
Sales	117.67M	P/S	5.07	EPS this Y	-	Inst Trans	-9.83%	Short Ratio	6.32	Perf Half Y	14.53%
Book/sh	77.93	P/B	0.23	EPS next Y	-	ROA	-	Short Interest	4.90M	Perf Year	-
Cash/sh	25.40	P/C	0.70	EPS next 5Y	-	ROE	-	52W Range	12.33 - 24.92	Perf YTD	-0.61%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-110.15%	ROI	-80.02%	52W High	-28.81%	Beta	-
Dividend TTM	-	Quick Ratio	9.43	Sales past 5Y	173.89%	Gross Margin	-68.59%	52W Low	43.89%	ATR (14)	1.64
Dividend Ex-Date	-	Current Ratio	9.65	EPS Y/Y TTM	-	Oper. Margin	-685.71%	RSI (14)	45.40	Volatility	6.24% 10.39%
Employees	-	Debt/Eq	0.03	Sales Y/Y TTM	-	Profit Margin	-1799.51%	Recom	3.00	Target Price	16.00
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	86.82%	Payout	-	Rel Volume	0.52	Prev Close	17.85
Sales Surprise	-15.48%	EPS Surprise	38.72%	Sales Q/Q	38.27%	Earnings	Nov 12 AMC	Avg Volume	774.45K	Price	17.74
SMA20	-11.45%	SMA50	3.83%	SMA200	12.51%	Trades		Volume	292,538	Change	-0.61%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-27-24	Initiated	Morgan Stanley	Equal-Weight	$16
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Oct-17-24	Initiated	Guggenheim	Neutral

Dec-18-24 04:01PM	GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) -23.41% -5.25%
Dec-16-24 01:43PM	What's Going On With Illumina Stock On Monday? (Benzinga)
Dec-10-24 02:52PM	One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's (Investor's Business Daily) -6.03%
Dec-05-24 01:40PM	Stock Market Today: Dow Jones Keeps Losses Tidy As New Medical IPO Breaks Out (Live Coverage) (Investor's Business Daily) +10.78%
Dec-03-24 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
04:05PM	Loading…
Nov-19-24 04:05PM	GRAIL to Participate in Upcoming Investor Conferences (PR Newswire) +5.64%
Nov-18-24 04:01PM	GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study (PR Newswire) -5.41%
09:16AM	Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-14-24 02:00PM	GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com)
Nov-12-24 04:06PM	GRAIL Reports Third Quarter 2024 Financial Results (PR Newswire) +5.50%
Nov-04-24 04:01PM	GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
Oct-29-24 04:01PM	GRAIL to Announce Third Quarter 2024 Financial Results (PR Newswire)
Oct-23-24 06:00PM	GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference (PR Newswire) -5.12%
Oct-21-24 04:01PM	GRAIL Appoints Sarah Krevans to Board of Directors (PR Newswire)
Oct-16-24 02:00AM	Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer (GlobeNewswire)
04:59PM	Loading…
Oct-13-24 04:59PM	GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now (Insider Monkey)
Sep-30-24 09:04PM	CRCM LP's Strategic Acquisition of GRAIL Inc Shares (GuruFocus.com)
Sep-03-24 11:37AM	Illumina Wins Court Fight With EU Over $7 Billion Grail Deal (Bloomberg) -6.02%
Aug-30-24 05:55PM	GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) (PR Newswire)
Aug-29-24 04:16PM	Results of GRAIL's Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology (PR Newswire)
Aug-21-24 04:01PM	GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) +5.35%
Aug-17-24 10:05PM	Illumina, Inc. (ILMN): Is This Cheap Robotic Stock a Good Buy Right Now? (Insider Monkey)
Aug-16-24 08:01PM	10 Cheap Robotics Stocks To Buy (Insider Monkey) +5.55%
Aug-14-24 08:07AM	Grail to shed 350 workers in restructuring (MedTech Dive)
Aug-13-24 04:01PM	GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update (PR Newswire)
Aug-08-24 08:05AM	Wheels Up Announces Gregory Summe to Join Board of Directors (PR Newswire)
Jul-31-24 04:05PM	GRAIL to Announce Second Quarter 2024 Financial Results (PR Newswire) +8.19%
Jul-24-24 08:55AM	Heres Why You Should Add Illumina (ILMN) to Your Portfolio (Insider Monkey)
Jul-19-24 06:53AM	Grail announces first patients enrolled in REACH cancer trial (Medical Device Network)
Jul-18-24 09:00AM	GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri Multi-Cancer Early Detection (MCED) Test in the Medicare Population (PR Newswire) -14.63%
06:30AM	Loading…
Jul-17-24 06:30AM	3 Top Cancer Treatment Stocks to Buy Now (InvestorPlace)
Jul-15-24 12:31PM	3 Spinoff Stocks You Should Buy Now: July 2024 (InvestorPlace) +5.27%
03:01AM	GRAIL Advances the Galleri Registrational Clinical Trial Program (PR Newswire)
Jul-05-24 06:55AM	3 Biotech Stocks Turning DNA Dreams Into Dollars (InvestorPlace)
Jun-28-24 01:02AM	Gene-sequencing group Illumina sees $1.47 bn Q2 impairment charge linked to Grail (Investing.com)
Jun-27-24 05:26PM	Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2 (Reuters) -9.38%

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Freidin Aaron	Chief Financial Officer	Nov 18 '24	Sale	14.02	30,452	426,937	268,277	Nov 19 04:06 PM
Aaron Freidin	Officer	Nov 18 '24	Proposed Sale	14.80	31,721	469,471		Nov 15 06:38 PM
RAGUSA ROBERT P	Chief Executive Officer	Oct 15 '24	Sale	14.02	123,454	1,730,825	612,661	Oct 17 06:32 PM
Robert Ragusa	Officer	Oct 14 '24	Proposed Sale	14.49	135,454	1,962,728		Oct 11 06:01 PM
DING CHUN R	10% Owner	Oct 03 '24	Buy	12.71	35,000	444,850	3,558,655	Oct 10 07:45 PM
DING CHUN R	10% Owner	Oct 02 '24	Buy	13.37	20,000	267,400	3,523,655	Oct 10 07:45 PM
DING CHUN R	10% Owner	Oct 09 '24	Buy	12.92	16,200	209,304	3,644,855	Oct 10 07:45 PM
DING CHUN R	10% Owner	Oct 01 '24	Buy	13.52	7,629	103,144	3,503,655	Oct 10 07:45 PM
Joshua J. Ofman	Officer	Aug 21 '24	Proposed Sale	16.25	74,084	1,203,650		Oct 07 08:38 PM
Aaron Freidin	Officer	Aug 21 '24	Proposed Sale	16.25	15,641	254,121		Oct 07 08:37 PM
Freidin Aaron	Chief Financial Officer	Aug 21 '24	Sale	16.25	15,641	254,121	173,429	Aug 22 04:02 PM
Ofman Joshua J.	President	Aug 21 '24	Sale	16.25	74,084	1,203,650	191,757	Aug 22 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRAL

GRAIL Inc

Upgrade your FINVIZ experience